BIOGEN INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOGEN INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOGEN INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 1,988 | 0 | 0 | |
| Feb 25 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 347.11 | 940 | 326,283 | 22,455 | 23.4 K to 22.5 K (-4.02 %) |
| Feb 25 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 1,988 | 0 | 23,395 | 21.4 K to 23.4 K (+9.29 %) |
| Feb 27 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 342.17 | 1,048 | 358,594 | 21,407 | 22.5 K to 21.4 K (-4.67 %) |
| Feb 25 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 4,280 | 0 | 0 | |
| Feb 25 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 347.11 | 2,018 | 700,468 | 15,455 | 17.5 K to 15.5 K (-11.55 %) |
| Feb 25 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 4,280 | 0 | 17,473 | 13.2 K to 17.5 K (+32.44 %) |
| Feb 25 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 2,598 | 0 | 0 | |
| Feb 25 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 347.11 | 1,228 | 426,251 | 25,478 | 26.7 K to 25.5 K (-4.60 %) |
| Feb 25 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 2,598 | 0 | 26,706 | 24.1 K to 26.7 K (+10.78 %) |
| Feb 19 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Sell | S | 327.90 | 1,222 | 400,694 | 9,412 | 10.6 K to 9.4 K (-11.49 %) |
| Feb 25 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 3,821 | 0 | 0 | |
| Feb 25 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 347.11 | 1,803 | 625,839 | 22,127 | 23.9 K to 22.1 K (-7.53 %) |
| Feb 25 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 3,821 | 0 | 23,930 | 20.1 K to 23.9 K (+19.00 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | A | 0.00 | 8,010 | 0 | 8,010 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | M | 0.00 | 3,573 | 0 | 10,722 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Payment of Exercise | F | 323.04 | 1,685 | 544,322 | 11,481 | 13.2 K to 11.5 K (-12.80 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Buy | M | 0.00 | 3,573 | 0 | 13,166 | 9.6 K to 13.2 K (+37.25 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | A | 0.00 | 7,340 | 0 | 7,340 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 2,807 | 0 | 8,422 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 323.04 | 1,324 | 427,705 | 13,193 | 14.5 K to 13.2 K (-9.12 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 2,807 | 0 | 14,517 | 11.7 K to 14.5 K (+23.97 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 2,400 | 0 | 2,400 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 714 | 0 | 2,144 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Payment of Exercise | F | 323.04 | 239 | 77,207 | 1,702 | 1.9 K to 1.7 K (-12.31 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Artavanis-Tsakonas Spyridon | SVP, Chief Scientif ... | Buy | M | 0.00 | 714 | 0 | 1,941 | 1.2 K to 1.9 K (+58.19 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 8,010 | 0 | 8,010 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 2,142 | 0 | 6,431 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 323.04 | 1,010 | 326,270 | 20,109 | 21.1 K to 20.1 K (-4.78 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 2,142 | 0 | 21,119 | 19 K to 21.1 K (+11.29 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | A | 0.00 | 13,340 | 0 | 13,340 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 792 | 0 | 2,381 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 316.42 | 425 | 134,478 | 21,407 | 21.8 K to 21.4 K (-1.95 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Grant | A | 0.00 | 7,740 | 0 | 21,832 | 14.1 K to 21.8 K (+54.92 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 323.04 | 367 | 118,556 | 14,092 | 14.5 K to 14.1 K (-2.54 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 792 | 0 | 14,459 | 13.7 K to 14.5 K (+5.79 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | A | 0.00 | 7,340 | 0 | 7,340 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,142 | 0 | 6,431 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 323.04 | 1,010 | 326,270 | 10,634 | 11.6 K to 10.6 K (-8.67 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,142 | 0 | 11,644 | 9.5 K to 11.6 K (+22.54 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | A | 0.00 | 770 | 0 | 770 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Option Exercise | M | 0.00 | 315 | 0 | 945 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Payment of Exercise | F | 323.04 | 8 | 2,584 | 682 | 690 to 682 (-1.16 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | COVINO GREGORY F | VP, Chief Accountin ... | Buy | M | 0.00 | 315 | 0 | 690 | 375 to 690 (+84.00 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | A | 0.00 | 7,470 | 0 | 7,470 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,246 | 0 | 6,741 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Sell | S | 316.81 | 1,290 | 408,685 | 0 | 1.3 K to 0 (-100.00 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 323.04 | 956 | 308,826 | 1,290 | 2.2 K to 1.3 K (-42.56 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 2,246 | 0 | 2,246 | 0 to 2.2 K |
| Feb 14 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | A | 0.00 | 31,490 | 0 | 31,490 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 9,189 | 0 | 27,569 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 316.81 | 486 | 153,970 | 57,331 | 57.8 K to 57.3 K (-0.84 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 323.04 | 4,333 | 1,399,732 | 57,817 | 62.2 K to 57.8 K (-6.97 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 9,189 | 0 | 62,150 | 53 K to 62.2 K (+17.35 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | A | 0.00 | 7,340 | 0 | 7,340 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 2,246 | 0 | 6,741 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 323.04 | 1,059 | 342,099 | 24,108 | 25.2 K to 24.1 K (-4.21 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 2,246 | 0 | 25,167 | 22.9 K to 25.2 K (+9.80 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | A | 0.00 | 6,670 | 0 | 6,670 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 2,246 | 0 | 6,741 | |
| Feb 14 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 323.04 | 1,059 | 342,099 | 11,939 | 13 K to 11.9 K (-8.15 %) |
| Feb 14 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 2,246 | 0 | 12,998 | 10.8 K to 13 K (+20.89 %) |
| Feb 12 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 314.31 | 855 | 268,735 | 13,667 | 14.5 K to 13.7 K (-5.89 %) |
| Feb 12 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Sell | S | 314.31 | 1,230 | 386,601 | 14,522 | 15.8 K to 14.5 K (-7.81 %) |
| Feb 12 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 314.31 | 1,493 | 469,265 | 52,961 | 54.5 K to 53 K (-2.74 %) |
| Feb 12 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 314.31 | 963 | 302,681 | 54,454 | 55.4 K to 54.5 K (-1.74 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 18,833 | 0 | 18,833 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,270 | 0 | 22,544 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 315.54 | 8,880 | 2,801,995 | 55,417 | 64.3 K to 55.4 K (-13.81 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 18,833 | 0 | 64,297 | 45.5 K to 64.3 K (+41.42 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 315.54 | 4,850 | 1,530,369 | 45,464 | 50.3 K to 45.5 K (-9.64 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 11,270 | 0 | 50,314 | 39 K to 50.3 K (+28.86 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 1,824 | 0 | 1,824 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 2,636 | 0 | 5,275 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 315.54 | 861 | 271,680 | 10,752 | 11.6 K to 10.8 K (-7.41 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 1,824 | 0 | 11,613 | 9.8 K to 11.6 K (+18.63 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 315.54 | 1,243 | 392,216 | 9,789 | 11 K to 9.8 K (-11.27 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 2,636 | 0 | 11,032 | 8.4 K to 11 K (+31.40 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 4,691 | 0 | 4,691 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Option Exercise | M | 0.00 | 3,191 | 0 | 6,385 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 315.54 | 2,212 | 697,974 | 11,710 | 13.9 K to 11.7 K (-15.89 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 4,691 | 0 | 13,922 | 9.2 K to 13.9 K (+50.82 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Payment of Exercise | F | 315.54 | 1,047 | 330,370 | 9,231 | 10.3 K to 9.2 K (-10.19 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Clancy Paul J | Executive VP and CF ... | Buy | M | 0.00 | 3,191 | 0 | 10,278 | 7.1 K to 10.3 K (+45.03 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | M | 0.00 | 3,468 | 0 | 6,939 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Payment of Exercise | F | 315.54 | 1,636 | 516,223 | 9,593 | 11.2 K to 9.6 K (-14.57 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Buy | M | 0.00 | 3,468 | 0 | 11,229 | 7.8 K to 11.2 K (+44.68 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 2,705 | 0 | 5,414 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 315.54 | 1,276 | 402,629 | 9,502 | 10.8 K to 9.5 K (-11.84 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 2,705 | 0 | 10,778 | 8.1 K to 10.8 K (+33.51 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 1,824 | 0 | 1,824 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Option Exercise | M | 0.00 | 1,277 | 0 | 2,555 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 315.54 | 594 | 187,431 | 15,752 | 16.3 K to 15.8 K (-3.63 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 1,824 | 0 | 16,346 | 14.5 K to 16.3 K (+12.56 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Payment of Exercise | F | 315.54 | 422 | 133,158 | 14,522 | 14.9 K to 14.5 K (-2.82 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Sandrock Alfred | Grp SVP, Chief Medi ... | Buy | M | 0.00 | 1,277 | 0 | 14,944 | 13.7 K to 14.9 K (+9.34 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 3,909 | 0 | 3,909 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 2,498 | 0 | 4,996 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 315.54 | 1,746 | 550,933 | 18,977 | 20.7 K to 19 K (-8.43 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 3,909 | 0 | 20,723 | 16.8 K to 20.7 K (+23.25 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Payment of Exercise | F | 315.54 | 819 | 258,427 | 16,814 | 17.6 K to 16.8 K (-4.64 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | ALEXANDER SUSAN H | EVP, Chief Legal Of ... | Buy | M | 0.00 | 2,498 | 0 | 17,633 | 15.1 K to 17.6 K (+16.50 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 4,691 | 0 | 4,691 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Option Exercise | M | 0.00 | 4,023 | 0 | 8,049 | |
| Feb 11 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 315.54 | 2,212 | 697,974 | 22,921 | 25.1 K to 22.9 K (-8.80 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 4,691 | 0 | 25,133 | 20.4 K to 25.1 K (+22.95 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Payment of Exercise | F | 315.54 | 1,441 | 454,693 | 20,442 | 21.9 K to 20.4 K (-6.59 %) |
| Feb 11 2014 | IDPH | BIOGEN INC. | Cox John | EVP Pharmaceutical ... | Buy | M | 0.00 | 4,023 | 0 | 21,883 | 17.9 K to 21.9 K (+22.53 %) |
| Feb 05 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Sell | S | 299.01 | 1,655 | 494,862 | 0 | 1.7 K to 0 (-100.00 %) |
| Feb 03 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Option Exercise | M | 0.00 | 2,463 | 0 | 4,930 | |
| Feb 03 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Payment of Exercise | F | 312.64 | 808 | 252,613 | 1,655 | 2.5 K to 1.7 K (-32.81 %) |
| Feb 03 2014 | IDPH | BIOGEN INC. | DiPietro Kenneth | EVP Human Resources | Buy | M | 0.00 | 2,463 | 0 | 2,463 | 0 to 2.5 K |
| Feb 03 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Option Exercise | M | 0.00 | 5,159 | 0 | 5,157 | |
| Feb 03 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Payment of Exercise | F | 312.64 | 1,969 | 615,588 | 7,761 | 9.7 K to 7.8 K (-20.24 %) |
| Feb 03 2014 | IDPH | BIOGEN INC. | WILLIAMS DOUGLAS E | EVP Research & Deve ... | Buy | M | 0.00 | 5,159 | 0 | 9,730 | 4.6 K to 9.7 K (+112.86 %) |
| Feb 03 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Option Exercise | M | 0.00 | 4,586 | 0 | 0 | |
| Feb 03 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Payment of Exercise | F | 312.64 | 1,701 | 531,801 | 8,396 | 10.1 K to 8.4 K (-16.85 %) |
| Feb 03 2014 | IDPH | BIOGEN INC. | Kingsley Stuart A | EVP, Global Comm. O ... | Buy | M | 0.00 | 4,586 | 0 | 10,097 | 5.5 K to 10.1 K (+83.22 %) |
| Feb 03 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Option Exercise | M | 0.00 | 5,159 | 0 | 5,157 | |
| Feb 03 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Payment of Exercise | F | 312.64 | 1,971 | 616,213 | 8,073 | 10 K to 8.1 K (-19.62 %) |
| Feb 03 2014 | IDPH | BIOGEN INC. | Holtzman Steven H | EVP Corporate Devel ... | Buy | M | 0.00 | 5,159 | 0 | 10,044 | 4.9 K to 10 K (+105.61 %) |